Description: For UK HCPs only | Information about Ondexxya® (andexanet alfa) including approved indications for use in the UK and treatment guidelines
Prescribing information for Ondexxya ® can be found here: Great Britain | Northern Ireland
Ondexxya ® (andexanet alfa) has conditional marketing authorisation. This was granted because Ondexxya ® addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data.
Ondexxya ® is a haemostatic agent that is indicated for use in adult patients treated with apixaban or rivaroxaban (factor Xa inhibitors) when anticoagulation reversal is required due to major bleeds. 1,2